000147775 001__ 147775
000147775 005__ 20240229112657.0
000147775 0247_ $$2doi$$a10.1038/s41571-019-0177-5
000147775 0247_ $$2pmid$$apmid:30733593
000147775 0247_ $$2pmc$$apmc:PMC6650350
000147775 0247_ $$2ISSN$$a1743-4254
000147775 0247_ $$2ISSN$$a1743-4262
000147775 0247_ $$2ISSN$$a1759-4774
000147775 0247_ $$2ISSN$$a1759-4782
000147775 0247_ $$2altmetric$$aaltmetric:55076290
000147775 037__ $$aDKFZ-2019-02749
000147775 041__ $$aeng
000147775 082__ $$a610
000147775 1001_ $$0P:(DE-HGF)0$$aAldape, Kenneth$$b0
000147775 245__ $$aChallenges to curing primary brain tumours.
000147775 260__ $$aNew York, NY$$bNature Publ. Group$$c2019
000147775 3367_ $$2DRIVER$$aarticle
000147775 3367_ $$2DataCite$$aOutput Types/Journal article
000147775 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1575276202_24216
000147775 3367_ $$2BibTeX$$aARTICLE
000147775 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147775 3367_ $$00$$2EndNote$$aJournal Article
000147775 520__ $$aDespite decades of research, brain tumours remain among the deadliest of all forms of cancer. The ability of these tumours to resist almost all conventional and novel treatments relates, in part, to the unique cell-intrinsic and microenvironmental properties of neural tissues. In an attempt to encourage progress in our understanding and ability to successfully treat patients with brain tumours, Cancer Research UK convened an international panel of clinicians and laboratory-based scientists to identify challenges that must be overcome if we are to cure all patients with a brain tumour. The seven key challenges summarized in this Position Paper are intended to serve as foci for future research and investment.
000147775 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000147775 588__ $$aDataset connected to CrossRef, PubMed,
000147775 7001_ $$0P:(DE-HGF)0$$aBrindle, Kevin M$$b1
000147775 7001_ $$0P:(DE-HGF)0$$aChesler, Louis$$b2
000147775 7001_ $$0P:(DE-HGF)0$$aChopra, Rajesh$$b3
000147775 7001_ $$0P:(DE-HGF)0$$aGajjar, Amar$$b4
000147775 7001_ $$0P:(DE-HGF)0$$aGilbert, Mark R$$b5
000147775 7001_ $$0P:(DE-HGF)0$$aGottardo, Nicholas$$b6
000147775 7001_ $$0P:(DE-HGF)0$$aGutmann, David H$$b7
000147775 7001_ $$0P:(DE-HGF)0$$aHargrave, Darren$$b8
000147775 7001_ $$0P:(DE-HGF)0$$aHolland, Eric C$$b9
000147775 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David T W$$b10$$udkfz
000147775 7001_ $$0P:(DE-HGF)0$$aJoyce, Johanna A$$b11
000147775 7001_ $$0P:(DE-HGF)0$$aKearns, Pamela$$b12
000147775 7001_ $$0P:(DE-HGF)0$$aKieran, Mark W$$b13
000147775 7001_ $$0P:(DE-HGF)0$$aMellinghoff, Ingo K$$b14
000147775 7001_ $$0P:(DE-HGF)0$$aMerchant, Melinda$$b15
000147775 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan M$$b16$$udkfz
000147775 7001_ $$0P:(DE-HGF)0$$aPollard, Steven M$$b17
000147775 7001_ $$00000-0002-6557-895X$$aRamaswamy, Vijay$$b18
000147775 7001_ $$0P:(DE-HGF)0$$aRich, Jeremy N$$b19
000147775 7001_ $$00000-0001-7441-9486$$aRobinson, Giles W$$b20
000147775 7001_ $$0P:(DE-HGF)0$$aRowitch, David H$$b21
000147775 7001_ $$0P:(DE-HGF)0$$aSampson, John H$$b22
000147775 7001_ $$0P:(DE-HGF)0$$aTaylor, Michael D$$b23
000147775 7001_ $$0P:(DE-HGF)0$$aWorkman, Paul$$b24
000147775 7001_ $$00000-0001-7539-9472$$aGilbertson, Richard J$$b25
000147775 773__ $$0PERI:(DE-600)2491414-9$$a10.1038/s41571-019-0177-5$$gVol. 16, no. 8, p. 509 - 520$$n8$$p509 - 520$$tNature reviews / Clinical oncology Clinical oncology [...]$$v16$$x1759-4782$$y2019
000147775 909CO $$ooai:inrepo02.dkfz.de:147775$$pVDB
000147775 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000147775 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000147775 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000147775 9141_ $$y2019
000147775 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000147775 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147775 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147775 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNAT REV CLIN ONCOL : 2017
000147775 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147775 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000147775 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147775 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147775 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147775 915__ $$0StatID:(DE-HGF)9920$$2StatID$$aIF >= 20$$bNAT REV CLIN ONCOL : 2017
000147775 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x0
000147775 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x1
000147775 980__ $$ajournal
000147775 980__ $$aVDB
000147775 980__ $$aI:(DE-He78)B360-20160331
000147775 980__ $$aI:(DE-He78)B062-20160331
000147775 980__ $$aUNRESTRICTED